Stock PLX PROTALIX BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Protalix BioTherapeutics, Inc. TEL AVIV STOCK EXCHANGE

Equities

PLX

US74365A3095

Delayed TEL AVIV STOCK EXCHANGE
Other stock markets
 11:24:48 2023-03-21 am EDT 		5-day change 1st Jan Change
732.5 ILa -.--% Intraday chart for Protalix BioTherapeutics, Inc. +3.29% +69.68%
Mar. 14 Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024
Mar. 14 Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Protalix BioTherapeutics' Price Target to $10 From $7, Keeps Buy Rating
MT
PROTALIX BIOTHERAPEUTICS : HC Wainwright Adjusts Price Target on Protalix BioTherapeutics to $7 From $11, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PLX Stock
  4. PLX Stock
  5. News Protalix BioTherapeutics, Inc.
  6. Analyst Reco.